Doxorubicin pathways

2010/11/04 by Caroline F. Thorn, Connie Oshiro, Sharon Marsh +4 · 3 citations
Medicine · #Chemotherapy-induced cardiotoxicity and mitigation #Cancer Treatment and Pharmacology #Chronic Myeloid Leukemia Treatments

paper · doi:10.1097/fpc.0b013e32833ffb56

openalex publication_date 2010/11/04 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/05

Abstract

Thorn, Caroline F.; Oshiro, Connie; Marsh, Sharon; Hernandez-Boussard, Tina; McLeod, Howard; Klein, Teri E.; Altman, Russ B. Author Information

Citations

• Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius

Cited by

• DNA topoisomerases as molecular targets for anticancer drugs
• Co-delivery of icariside II and doxorubicin by self-assembled carrier-free nanofibers for anti-lung cancer therapy
• Topoisomerase inhibitor [wikipedia]

Related

• Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
• Anthracyclines
• First Use of Intravenous Chemotherapy Cancer Treatment: Rectifying the Record
• Series Introduction: Taking aim at novel molecular targets in cancer therapy
• Evarts A. Graham and the First Pneumonectomy for Lung Cancer